Cited by 93Artificial Intelligence in Healthcare and EducationArtificial Intelligence in HealthcareInternet of Things and AI

Artificial Intelligence and Machine Learning Applied at the Point of Care

Open access
Angehrn, Zuzanna, Haldna, Liina, Zandvliet, Anthe S., Gil Berglund, Eva, Zeeuw, Joost, Amzal, Billy, Cheung, S. Y. Amy, Polasek, Thomas M. +3 more·2020·Frontiers in Pharmacology

Abstract

INTRODUCTION: The increasing availability of healthcare data and rapid development of big data analytic methods has opened new avenues for use of Artificial Intelligence (AI)- and Machine Learning (ML)-based technology in medical practice. However, applications at the point of care are still scarce. OBJECTIVE: Review and discuss case studies to understand current capabilities for applying AI/ML in the healthcare setting, and regulatory requirements in the US, Europe and China. METHODS: A targeted narrative literature review of AI/ML based digital tools was performed. Scientific publications (identified in PubMed) and grey literature (identified on the websites of regulatory agencies) were reviewed and analyzed. RESULTS: From the regulatory perspective, AI/ML-based solutions can be considered medical devices (i.e., Software as Medical Device, SaMD). A case series of SaMD is presented. First, tools for monitoring and remote management of chronic diseases are presented. Second, imaging applications for diagnostic support are discussed. Finally, clinical decision support tools to facilitate the choice of treatment and precision dosing are reviewed. While tested and validated algorithms for precision dosing exist, their implementation at the point of care is limited, and their regulatory and commercialization pathway is not clear. Regulatory requirements depend on the level of risk associated with the use of the device in medical practice, and can be classified into administrative (manufacturing and quality control), software-related (design, specification, hazard analysis, architecture, traceability, software risk analysis, cybersecurity, etc.), clinical evidence (including patient perspectives in some cases), non-clinical evidence (dosing validation and biocompatibility/toxicology) and other, such as e.g. benefit-to-risk determination, risk assessment and mitigation. There generally is an alignment between the US and Europe. China additionally requires that the clinical evidence is applicable to the Chinese population and recommends that a third-party central laboratory evaluates the clinical trial results. CONCLUSIONS: The number of promising AI/ML-based technologies is increasing, but few have been implemented widely at the point of care. The need for external validation, implementation logistics, and data exchange and privacy remain the main obstacles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2020.00759

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. Banks A. (2019). “Requirements Assurance in Machine Learning”, (ed.) S (United Kingdom.): Defence Science and Technology Laboratory).
  2. Fleming N. (2018). Computer-calculated compounds: researchers are deploying artificial intelligence to discover drugs. Nature 557, S55. 29849160
  3. Mitchell T. (1997). Machine Learning. (McGrawHill, New York, NY, United States: McGraw-Hill).
  4. NMPA (2019). Draft Guidance on review for using deep learning to assist decision-making in medical devices software (深度学习辅助决策医疗器械软件审评要点及相关说明, 稿), Available: https://www.cmde.org.cn/directory/web/WS01/images/ye62yNGnz7C4qNb6vvay39K9wcbG99C1yO28snzxsDSqrXjLmRvYw==.doc [Accessed 1 November 2019].

Cited by

Sorted by citations

Authors
Angehrn, Z., Haldna, L., Zandvliet, A. S., Gil Berglund, E., Zeeuw, J., Amzal, B., Cheung, S. Y. A., Polasek, T. M., Pfister, M., Kerbusch, T., & Heckman, N. M.
Affiliations
  • Certara (United States) (US)
  • Royal Adelaide Hospital (AU)
Corresponding author
Zandvliet, Anthe S.
Venue
Frontiers in Pharmacology
Published
2020-06-18
Volume
11
Pages
759-759
ISSN
1663-9812 (ISSN-L)
OpenAlex
W3030588587
Cited by
93
References
39
Citations by year
2026: 14 · 2025: 15 · 2024: 27 · 2023: 10 · 2022: 16 · 2021: 10 · 2020: 1
FWCI
0.70
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Physical Sciences › Computer Science › Information Systems › Internet of Things and AI
Keywords
artificial intelligence in healthcare, machine learning, point of care, software as a medical device, regulatory requirements, precision dosing, clinical decision support, software risk analysis, external validation, data privacy, implementation barriers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review